Vimarsana
Biggest News Aggregation in the World

Page 21 - Stageone Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stageone Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stageone Ventures Today - Breaking & Trending Today

Follow the Money: Single-Cell Multiomics, Data Networks, Security - Vimarsana News

Follow the Money: Single-Cell Multiomics, Data Networks, Security

April 1, 2021 By Bio-IT World Staff April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.   $969M Investment Fund for Early to Late-Stage Companies Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresit...

Israeli AI surgical intelligence co Theator raises $15.5m - Vimarsana News

Israeli AI surgical intelligence co Theator raises $15.5m

Israeli AI surgical intelligence co Theator raises $15.5m Theator's AI-powered platform is based on smart annotation and cutting edge. Israeli AI surgical intelligence platform company Theator today announced that it has completed a $15.5 million oversubscribed Series A financing round led by Insight Partners, with new investor Blumberg Capital, and existing investors including NFX, StageOne Ventures, KdT Ventures, and iAngels. Notable individual investors including 23andMe's cofounder and CEO Anne Wojcicki, former Netflix CPO Neil Hunt, and Zebra Medical Vision's cofounder Eyal Gura also par...

Theator Nabs $15.5M to Scale AI-Driven Surgical Intelligence Platform - Vimarsana News

Theator Nabs $15.5M to Scale AI-Driven Surgical Intelligence Platform

Theator Nabs $15.5M to Scale AI-Driven Surgical Intelligence Platform What You Should Know: – Theator raises $15.5M in Series A funding to support the company’s mission of using AI and computer vision to eradicate disparity and variability in surgical care. – The startup plans to use this round to scale its commercial operations and partnerships with U.S. providers, grow its R&D team and cement its status as a world-leading provider of AI-powered Surgical Intelligence solutions. Theator, a Palto Alto, CA-based Surgical Intelligence platform leveraging AI and computer vision to impro...

Theator's $15.5M for AI surgery insights, Bold's $7M for virtual exercise programs and more digital health funding news - Vimarsana News

Theator's $15.5M for AI surgery insights, Bold's $7M for virtual exercise programs and more digital health funding news

Share Theator, a Palo Alto company building an AI and computer vision platform for surgeons, has brought in a $15.5 million Series A round. Insight Partners led the raise, which also included new backer Blumberg Capital, prior investors NFX, StageOne Ventures, KdT Ventures, iAngels and a slew of individual investors. Theator's platform focuses on streamlining pre-operative preparations and post-operative reviews by analyzing video and identifying key moments and steps for surgeons. With the new funds, the company said it will be scaling its commercial operations and provider partnerships ...

Otonomo to land on NASDAQ via SPAC merger - Vimarsana News

Otonomo to land on NASDAQ via SPAC merger

Results for "" Otonomo to land on NASDAQ via SPAC merger Employees and stakeholders will have $60M to play with. Otonomo CEO: "It's easier gaining trust as a public company, rather than just an Israeli startup"... Oshry Alkeslasi / 2 Feb 2021 • 2 min read Israeli startup Otonomo announced its plans of going public on NASDAQ via SPAC, meaning merging with a existing public company - in this case Software Acquisition Group INC II. The merger is expected to be completed b...